Detalhe da pesquisa
1.
A retrospective study on the management of patients with rituximab refractory follicular lymphoma.
Br J Haematol
; 180(2): 217-223, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29230799
2.
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.
Support Care Cancer
; 26(1): 81-89, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756472
3.
PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.
Blood
; 124(3): 420-5, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916506
4.
Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients.
Blood
; 121(18): 3650-7, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525797
5.
Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.
Br J Haematol
; 164(2): 258-65, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24219359
6.
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Am J Hematol
; 89(11): 1024-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25052698
7.
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.
Leukemia
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38678093
8.
High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study.
Br J Haematol
; 162(2): 240-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23692641
9.
Effect of FCGR2A and FCGR3A variants on CLL outcome.
Blood
; 116(20): 4212-22, 2010 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20705761
10.
Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy.
Clin Cancer Res
; 14(20): 6690-6, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18927312
11.
ZOHé: A Prospective Study of the Use of Biosimilar Filgrastim Zarzio in Clinical Practice in Patients Treated With Chemotherapy for Lymphoid Malignancies.
Clin Lymphoma Myeloma Leuk
; 17(6): 362-369.e2, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622961
12.
Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial.
Lancet Haematol
; 4(6): e272-e282, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476440
13.
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients.
J Natl Cancer Inst
; 109(9)2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423407
14.
Safety of rituximab maintenance therapy in follicular lymphomas.
Leuk Res
; 30 Suppl 1: S16-21, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16750674
15.
Prognosis of follicular lymphomas.
Clin Lymphoma
; 6(1): 21-5, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15989702
16.
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.
Arch Intern Med
; 162(15): 1729-35, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12153376
17.
Rituximab by subcutaneous route.
Expert Rev Hematol
; 8(2): 147-53, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25749209
18.
Increasing treatment options in indolent non-Hodgkin's lymphoma.
Semin Oncol
; 29(2 Suppl 6): 2-6, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12040527
19.
Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
Haematologica
; 88(7): 811-23, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12857561
20.
Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma.
Leuk Lymphoma
; 44(9): 1503-8, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-14565651